Midterm outcome of off-pump bypass procedures versus drug-eluting stent for unprotected left main coronary artery disease
Annals of Thoracic Surgery, 07/05/2012
Yi G et al. – Patients with left main coronary artery (LMCA) disease who were treated with off–pump coronary artery bypass (OPCAB) showed better 5–year freedom from MACCEs in a real–world practice and in a patient matching cohort compared with the drug–eluting stenting group. TVR was the main factor that made the difference. The benefit of OPCAB was more prominent in distal LMCA lesions and in LMCA lesions with multivessel involvement.
